{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:30:35Z","timestamp":1783524635452,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmune encephalitis (AE) can present like a psychiatric disorder. We aimed to illustrate the psychiatric manifestations, course and management of AE in a paediatric cohort. Neuropsychiatric symptoms, investigations and treatment were retrospectively retrieved in 16 patients (mean age 11.31, SD 2.98) with an AE diagnosis at the liaison psychiatry services in two UK tertiary paediatric centres. Psychiatric presentation was characterised by an acute polysymptomatic (predominantly agitation, anger outbursts\/aggressiveness, hallucinations, and emotional lability) onset. Antipsychotics produced side effects and significant worsening of symptoms in four cases, and benzodiazepines were commonly used. This psychiatric phenotype should make clinicians suspect the diagnosis of AE and carefully consider use of treatments.<\/jats:p>","DOI":"10.1007\/s00406-021-01293-5","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T15:02:22Z","timestamp":1626534142000},"page":"477-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterizing the features and course of psychiatric symptoms in children and adolescents with autoimmune encephalitis"],"prefix":"10.1007","volume":"272","author":[{"given":"R","family":"Rosello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Girela-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7738-8910","authenticated-orcid":false,"given":"M","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,17]]},"reference":[{"issue":"6","key":"1293_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/edpract-2014-307402","volume":"100","author":"S Clews","year":"2015","unstructured":"Clews S, Jeyasing S, Lim M (2015) Fifteen-minute consultation: autoimmune encephalitis. Arch Dis Childhood Educ Pract Ed 100(6):282. https:\/\/doi.org\/10.1136\/edpract-2014-307402","journal-title":"Arch Dis Childhood Educ Pract Ed"},{"issue":"3","key":"1293_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000682","volume":"7","author":"MAAM de Bruijn","year":"2020","unstructured":"de Bruijn MAAM, Bruijstens AL, Bastiaansen AEM, van Sonderen A, Schreurs MWJ, Sillevis Smitt PAE, Hintzen RQ, Neuteboom RF, Titulaer MJ (2020) Pediatric autoimmune encephalitis: recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm 7(3):e682. https:\/\/doi.org\/10.1212\/NXI.0000000000000682","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"1293_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10(12):835\u2013844. https:\/\/doi.org\/10.1016\/S1473-3099(10)70222-X","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1293_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet Neurol 12(2):157\u2013165. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1","journal-title":"The Lancet Neurol"},{"issue":"3","key":"1293_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/WCO.0000000000000443","volume":"30","author":"RC Dale","year":"2017","unstructured":"Dale RC, Gorman MP, Lim M (2017) Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges. Curr Opin Neurol 30(3):334\u2013344. https:\/\/doi.org\/10.1097\/WCO.0000000000000443","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"1293_CR6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378(9):840\u2013851. https:\/\/doi.org\/10.1056\/NEJMra1708712","journal-title":"N Engl J Med"},{"issue":"1","key":"1293_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12883-020-1605-y","volume":"20","author":"J Shekunov","year":"2020","unstructured":"Shekunov J, Blacker CJ, Vande Voort JL, Tillema JM, Croarkin PE, Romanowicz M (2020) Immune mediated pediatric encephalitis\u2014need for comprehensive evaluation and consensus guidelines. BMC Neurol 20(1):44. https:\/\/doi.org\/10.1186\/s12883-020-1605-y","journal-title":"BMC Neurol"},{"issue":"4","key":"1293_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer M (2016) A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurol 15(4):391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9","journal-title":"The Lancet Neurol"},{"issue":"12","key":"1293_CR9","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/dmcn.13579","volume":"59","author":"ACC Ho","year":"2017","unstructured":"Ho ACC, Mohammad SS, Pillai SC, Tantsis E, Jones H, Ho R, Lim M, Hacohen Y, Vincent A, Dale RC (2017) High sensitivity and specificity in proposed clinical diagnostic criteria for anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol 59(12):1256\u20131260. https:\/\/doi.org\/10.1111\/dmcn.13579","journal-title":"Dev Med Child Neurol"},{"issue":"S1","key":"1293_CR10","first-page":"75","volume":"61","author":"C Benetou","year":"2019","unstructured":"Benetou C, Tsagkaris S (2019) Lim M (2019) Establishing early diagnosis and treatment of paediatric autoimmune encephalitis patients: How useful are the current diagnostic criteria? Dev Med Child Neurol 61(S1):75","journal-title":"Dev Med Child Neurol"},{"key":"1293_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000663","author":"T Cellucci","year":"2020","unstructured":"Cellucci T, Van Mater H, Graus F, Muscal E, Gallentine W, Klein-Gitelman MS, Benseler SM, Frankovich J, Gorman MP, Van Haren K, Dalmau J, Dale RC (2020) Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000663","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"1293_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet Neurol 18(11):1045\u20131057. https:\/\/doi.org\/10.1016\/S1474-4422(19)30244-3","journal-title":"The Lancet Neurol"},{"issue":"5","key":"1293_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/acps.12941","volume":"138","author":"N Warren","year":"2018","unstructured":"Warren N, Siskind D, O\u2019Gorman C (2018) Refining the psychiatric syndrome of anti- N -methyl- D -aspartate receptor encephalitis. Acta Psychiatr Scand 138(5):401\u2013408. https:\/\/doi.org\/10.1111\/acps.12941","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1293_CR14","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2020.55","volume":"6","author":"M Eyre","year":"2020","unstructured":"Eyre M, Kaushik A, Barrett E, King MD, Pollak T, Dale RC, Byrne S, Lim M (2020) Catatonic features in children and adolescents with N -methyl- D -aspartate receptor antibody encephalitis. BJ Psych Open 6(4):e71. https:\/\/doi.org\/10.1192\/bjo.2020.55","journal-title":"BJ Psych Open"},{"issue":"1","key":"1293_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","volume":"7","author":"TA Pollak","year":"2020","unstructured":"Pollak TA, Lennox BR, M\u00fcller S, Benros ME, Pr\u00fcss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Bechter K (2020) Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The Lancet Psychiatr 7(1):93\u2013108. https:\/\/doi.org\/10.1016\/S2215-0366(19)30290-1","journal-title":"The Lancet Psychiatr"},{"key":"1293_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000663","author":"T Cellucci","year":"2020","unstructured":"Cellucci T, Mater V, Graus HF, Muscal E, Gallentine W, Klein-Gitelman MS, Benseler SM, Frankovich J, Gorman MP, Van Haren K, Dalmau J, Dale RC (2020) Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000663","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"1293_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/CCM.0b013e3181cb0968","volume":"38","author":"G Davies","year":"2010","unstructured":"Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, Radcliffe J, Hirsch NP, Howard RS, Vincent A, Kullmann DM (2010) Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 38(2):679\u2013682. https:\/\/doi.org\/10.1097\/CCM.0b013e3181cb0968","journal-title":"Crit Care Med"},{"key":"1293_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-Diwani","year":"2019","unstructured":"Al-Diwani A, Handel A, Townsend L et al (2019) The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. The Lancet Psychiatr 6:235\u2013246. https:\/\/doi.org\/10.1016\/S2215-0366(19)30001-X","journal-title":"The Lancet Psychiatr"},{"key":"1293_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1176\/appi.neuropsych.17120343","volume":"31","author":"LL Gibson","year":"2019","unstructured":"Gibson LL, Pollak TA, Blackman G et al (2019) The psychiatric phenotype of anti-NMDA receptor encephalitis. JNP 31:70\u201379. https:\/\/doi.org\/10.1176\/appi.neuropsych.17120343","journal-title":"JNP"},{"key":"1293_CR20","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1017\/S0033291718003665","volume":"49","author":"RJ Gurrera","year":"2019","unstructured":"Gurrera RJ (2019) Frequency and temporal sequence of clinical features in adults with anti-NMDA receptor encephalitis presenting with psychiatric symptoms. Psychol Med 49:2709\u20132716. https:\/\/doi.org\/10.1017\/S0033291718003665","journal-title":"Psychol Med"},{"issue":"4","key":"1293_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/dmcn.12882","volume":"58","author":"SS Mohammad","year":"2016","unstructured":"Mohammad SS, Jones H, Hong M, Nosadini M, Sharpe C, Pillai SC, Brilot F, Dale RC (2016) Symptomatic treatment of children with anti-NMDAR encephalitis. Dev Med Child Neurol 58(4):376\u2013384. https:\/\/doi.org\/10.1111\/dmcn.12882","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"1293_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.chc.2016.12.014","volume":"26","author":"V Chan","year":"2017","unstructured":"Chan V (2017) Schizophrenia and psychosis. Child Adolesc Psychiatr Clin N Am 26(2):341\u2013366. https:\/\/doi.org\/10.1016\/j.chc.2016.12.014","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"5","key":"1293_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000280","volume":"3","author":"F Lejuste","year":"2016","unstructured":"Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Groc L, Leboyer M, Honnorat J (2016) Neuroleptic intolerance in patients with anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm 3(5):e280. https:\/\/doi.org\/10.1212\/NXI.0000000000000280","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"1293_CR24","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000130","volume":"2","author":"S Byrne","year":"2015","unstructured":"Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, Dale RC, Vincent A, Lim M, King M (2015) Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome: Table 1. Neurol Neuroimmunol Neuroinflamm 2(4):e130. https:\/\/doi.org\/10.1212\/NXI.0000000000000130","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"1293_CR25","first-page":"297","volume":"26","author":"SS Mohammad","year":"2014","unstructured":"Mohammad SS, Wallace G, Ramanathan S, Brilot F, Dale RC (2014) Antipsychotic-induced akathisia and neuroleptic malignant syndrome in anti-NMDAR encephalitis. Ann Clin Psychiatr Off J Am Acad Clin Psychiatr 26(4):297\u2013298","journal-title":"Ann Clin Psychiatr Off J Am Acad Clin Psychiatr"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-021-01293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-021-01293-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-021-01293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:06:18Z","timestamp":1647885978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-021-01293-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1007\/s00406-021-01293-5","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,17]]},"assertion":[{"value":"21 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Lim has received consultation fees from CSL Behring, Novartis and Octopharma, travel grants from Merck Serono, and been awarded educational grants to organise meetings by Novartis, Biogen Idec, Merck Serono and Bayer. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}